The global industrialization base for small molecule innovative drugs in Baiji Shenzhou has been launched
无由窗置
发表于 2023-11-16 16:05:53
1292
0
0
"Suzhou Industrial Park Released" WeChat official account news, on November 16, the global industrialization base of small molecule innovative drugs in Baekje China, located in Suzhou Industrial Park, was opened. The global industrialization base for small molecule innovative drugs launched this time has a construction area of approximately 50000 square meters, and it is expected to produce an annual solid formulation of up to 1 billion tablets/capsule after full completion.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- BeiGene (688235. SH): Chief Financial Officer Wang Aijun resigns due to seeking external development opportunities
- BeiGene Chief Financial Officer Resigns, Aaron Rosenberg Takes Over
- Eisai/Bojian Alzheimer's disease drug rejected by the European Union, and Eli Lilly monoclonal antibody may be affected
- AstraZeneca's market value has surpassed £ 200 billion for the first time! The bold bet on anti-cancer drugs is yielding results
- Bristol Myers Squibb's original tumor treatment drug Abraxane has been officially launched in China
- BeiGene responds to being sued again by AbbVie: denies allegations and will launch a firm defense
- BeiGene responds to investigation of company executives: the incident involving the employee has nothing to do with BeiGene
- BeiGene: An employee of the company is cooperating with the investigation and it is understood that the incident in question is not related to BeiGene
- BeiGene responds to employee cooperation investigation: the incident is not related to the company
- Lilly weight loss pills are now available for purchase on e-commerce platforms. Lilly China responds that they are self funded drugs